Rituximab treatment of myasthenia gravis: A systematic review.

Tandan, Rup; Hehir, Michael K; Waheed, Waqar; Howard, Diantha B

Tandan, Rup; Hehir, Michael K; Waheed, Waqar; Howard, Diantha B.

Afiliación

Tandan R; Department of Neurological Sciences, University of Vermont, Robert Larner College of Medicine and University of Vermont Medical Center, Room 426, Health Sciences Research Facility, 149 Beaumont Avenue, Burlington, Vermont, 05405, USA.
Hehir MK; Department of Neurological Sciences, University of Vermont, Robert Larner College of Medicine and University of Vermont Medical Center, Room 426, Health Sciences Research Facility, 149 Beaumont Avenue, Burlington, Vermont, 05405, USA.
Waheed W; Department of Neurological Sciences, University of Vermont, Robert Larner College of Medicine and University of Vermont Medical Center, Room 426, Health Sciences Research Facility, 149 Beaumont Avenue, Burlington, Vermont, 05405, USA.
Howard DB; Center for Clinical and Translational Science, University of Vermont, Robert Larner College of Medicine and University of Vermont Medical Center, Burlington, Vermont, USA.

Muscle Nerve ; 56(2): 185-196, 2017 08.

Article en En | MEDLINE | ID: mdl-28164324

Asunto(s)

Factores Inmunológicos/uso terapéutico; Miastenia Gravis/tratamiento farmacológico; Rituximab/uso terapéutico; Humanos; Miastenia Gravis/inmunología

Palabras clave

B-cell depletion; acetylcholine receptor antibody; muscle-specific tyrosine kinase; myasthenia gravis; rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rituximab / Factores Inmunológicos / Miastenia Gravis Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Muscle Nerve Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google